Evogene (EVGN) Non-Current Deffered Revenue (2016 - 2018)

Evogene (EVGN) has disclosed Non-Current Deffered Revenue for 3 consecutive years, with $28000.0 as the latest value for Q4 2018.

  • Quarterly Non-Current Deffered Revenue fell 68.54% to $28000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $28000.0 through Dec 2018, down 68.54% year-over-year, with the annual reading at $28000.0 for FY2018, 68.54% down from the prior year.
  • Non-Current Deffered Revenue hit $28000.0 in Q4 2018 for Evogene, down from $89000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $138000.0 in Q4 2016 to a low of $28000.0 in Q4 2018.
  • Historically, Non-Current Deffered Revenue has averaged $85000.0 across 3 years, with a median of $89000.0 in 2017.
  • Biggest five-year swings in Non-Current Deffered Revenue: plummeted 35.51% in 2017 and later crashed 68.54% in 2018.
  • Year by year, Non-Current Deffered Revenue stood at $138000.0 in 2016, then tumbled by 35.51% to $89000.0 in 2017, then plummeted by 68.54% to $28000.0 in 2018.
  • Business Quant data shows Non-Current Deffered Revenue for EVGN at $28000.0 in Q4 2018, $89000.0 in Q4 2017, and $138000.0 in Q4 2016.